India: A recent study published in the Journal of Clinical and Experimental Hepatology in June 2025 reports a high prevalence of transaminitis (25.9 percent) among young Indian adults, and that 27.4 ...
Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2025 financial results and provided a corporate update.
The ongoing IIT study (NCT07193615) is evaluating single doses administered via intravenous infusion of YOLT-202 at 35 mg, 45 mg and 55 mg dose levels. YolTech is actively preparing to file an IND ...
The peptidases can break bonds between specific D- and L-amino acids, filling a gap in the toolbox for natural products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results